The aim of this report is to provide an overview of experts’ experiences in the treatment and diagnostic challenges related to EGFR exon 20 insertion mutations in NSCLC, provided in based on the insights collected in the Virtual Meeting held from September 19 to October 30, 2022. Here, EGFR is linked to non-small cell lung carcinoma.